Funding Opportunities

Innovate UK, SBRI Healthcare & NHS

SBRI

The Small Business Research Initiative for Healthcare (SBRI Healthcare) is an NHS England initiative, championed by the Academic Health Science Networks (AHSNs), which supports a programme of competitions inviting companies to come forward with their ideas and new technologies for known NHS challenges. These ideas are assessed and a fully funded development contract is agreed between the company and the NHS.

The SBRI Healthcare programme has two primary-phases that start with an initial identification of unmet need, undertaken by clinicians. Challenges are offered to industry to test the feasibility of their ideas and these projects, if successful, can result in a contract to develop the product

SBRI Healthcare is a fast track, simplified process that enables the NHS to work with industry to tackle known challenges. Targeted at SMEs and early stage businesses it gives vital funding for a critical stage of product development. For details about how to apply and current and future completion thematic areas visit www.sbrihealthcare.co.uk 

DEPARTMENT OF HEALTH AND SOCIAL CARE

DHSC: Framework agreement for the supply of pralidoxime chloride
The provision of pralidoxime chloride for use as part of the stockpile of emergency medicines for in response to incidents.
Deadline: approach to market 3 June 2019
Click here for more information.

INNOVATE UK

KTPs: Next Funding Round
Projects can focus on any technology or industry area, and last between 1 to 3 years.
Applicants must:
• focus on a specific project
• set out the nature and goals of the project
• give details of who will take part
• establish what the graduate is expected to deliver
Deadline: 29 May 2019
Click here for more information.

Innovate UK: SME support to evaluate innovative medical technologies: Round 4
This competition is aimed at SMEs that have developed and manufactured innovative medical devices, diagnostics or regulated digital healthcare products.
You must have gained a CE marking for your product and it must already be available for the NHS to purchase, but not marketed in the UK for more than 5 years. You must collect supporting clinical evidence of its performance, cost effectiveness and impact in the NHS. If we decide to fund you, this evidence may help increase uptake of your product within the NHS.
The competition will support the development or design of plans for the collection of clinical data in a real-world setting, and also support the running of these studies.
Your project must:
• focus on understanding evidence gaps and testing product performance to explain the operational impact of your product on the NHS
• add data to the evidence base that can contribute to the health technology appraisal process, for instance by comparing the use of the new product with the current standard of care
• involve potential breakthrough technologies
• help improve methods and systems

Priority will be given to projects that are related to:
– ageing well
– cancer
– digital transformation
– learning disabilities and autism
– mental health
– personalised care
– prevention
– primary care
– starting well
–  stroke
–  workforce
Deadline: 3 July 2019
Click here to find out more.

Innovate UK: AI-supported early fracture diagnosis: SBRI competition
NHS Scotland and Opportunity North East (ONE) are investing up to £240,000, including VAT, in innovative data analytics technology. The aim is to improve front-line clinical decision making and patient management in unscheduled care facilities.
The solution will improve clinical workflow and safety by optimising clinical decision making and management pathways. It must use artificial intelligence (AI) or machine learning algorithms to interpret data from upper limb (wrist or hand) and lower limb (ankle or foot) radiographs and linked text-based reports. Accurate determination of the presence or absence of a fracture in these areas has the potential to significantly improve patient care.
Phase 1 research and development contracts will be focused on feasibility studies. Phase 2 contracts will be prototype development and testing.
Deadline: registration closes 24 July 2019, 12.00pm
Click here for more information.

Innovate UK: SMART programme
Innovate UK’s Smart programme is for the very best ideas from business, no matter what field they are in or the stage of innovation they are at, from testing the feasibility of an idea through to development and prototyping.
The programme is for business innovation projects that offer a major step-change, either to what’s already available or by developing an entirely new technology, service or process.
Innovate UK is looking for new game-changing or disruptive processes or services that have the potential to improve and transform people’s lives, industries and the world.
These ideas should have a considerable positive impact to UK productivity and the economy and a high potential for commercialisation within the UK and wider global markets.
All proposals must be business focused, rather than pure research. Applications can come from any area of technology (including arts, design, media or creative industries), science or engineering and be applied to any part of the economy
Deadline: 24 July 2019
Click here for more information.

NHS

NHS England + UK Space Agency: multi-million pound drive to improve patient care
The UK Space Agency has announced it is allocating up to £4 million to find hi-tech solutions to the major health and care challenges facing the NHS in its 70th anniversary year in a joint initiative with NHS England.
These challenges are:
•Managing long term conditions including joining up health and care services
•Earlier diagnosis of cancer
•Transforming GP services and other primary care
•Meeting mental health needs
Previous examples of space tech being adapted for NHS use include a pill camera that can be swallowed by patients, dementia tracking slippers, breast screening vans that beam images back to assessment centres, wearable monitors to help prevent falls among the elderly and apps that help prevent skin cancer.
Deadline: none stated
Click here for more information.

NHS TENDERS

NHS England: Supply of various medical products
Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

Specialised – Bleeding Disorders

Specialised – Normal Human Immunoglobulins 

Open future opportunity – This means that the buyer is not yet ready to invite applications, but early notification has been provided and some dialogue may be possible.

NHS Digital: Scale up local digital adult social care projects
Organisations that provide and commission adult social care services are invited to bid for a share of £4.8m to enable them to roll out their local digital projects on a wider scale.
Applications can be made by adult social care providers with not for profit status, local authorities and academic organisations based in England.  Partnerships and consortiums are welcomed and encouraged.
There are two main themes to this programme of work:
1. Use of standards to support whole health and care system interoperability, for example:
• sharing of information across the health and social care system to support efficient access to care, and for direct care
• real time event alerts that notify a social care provider when a citizen receiving social care support has been admitted to hospital, discharged from hospital and other appropriate flags
• removal of fax machines from care providers through the implementation of appropriate safe and secure messaging platforms between health, care providers and local authorities
2. Use of data for the prevention of escalating social care needs and for early intervention of those at risk of requiring social care, for example:
• predictive modelling for adult social care demands and needs across a population
• using data to highlight those whose combination of health, social and environmental indicators means that they are at higher risk of losing their independence
Deadline: 22 May 2019, 5.00pm.
Click here for more information.

NHS Supply Chain: Architectural Surgical Medical Systems Renewal 2022
NHS supply chain intends to launch a National Framework Agreement for the provision of lights, pendant systems,
theatre control units, tables, patient stretchers and trolleys, medical lasers including all variations specified
for use in a medical setting. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 16 870 000 GBP to 32 327 500 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options) is between 72 000 000 GBP and 150 364 000 GBP.
Deadline: 26 June 2019
Click here for more information.

NHS Supply Chain: Orthotic Services & Associated Consumables
CPP LLP acting as Agent on behalf of Supply Chain Co-ordinated Limited under NHS Supply Chain intend to establish an overarching non-exclusive Framework Agreement which NHS and Other Health Organisations can place orders and contractual agreements under, the scope of which will include Orthotic Services, Orthotic, Podiatry and associated consumables. The lot structure is intended to have a separate Lot for Orthotic Services, with consumables, modular and bespoke product; a Lot for Products only; and a Lot for Services only.
The intended commencement date for this potential framework agreement will be 01.05.2020 with a 2-year term, with a further option to extend in periods up to 30.04.2024.
Deadline: 5 July 2019
Click here for more information.

NHS Supply Chain: Patient Monitoring Equipment and Related Accessories/Services
NHS Supply Chain intends to launch a National Framework Agreement for the provision of the following types of Monitoring Systems:

– spot check
– vital signs
– patient (low, Mid and High Acuity)
– pre-hospital transport
– Magnetic Resonance Imaging (MRI) compatible
– central station
– telemetry
– foetal
– cardiac output, Electroencephalograph (EEG) and
– electromyography (EMG)
– transfer (individual patient modular monitor).

Please note that this framework will not cover the purchase of consumables alone. For the avoidance of doubt consumables will only be in scope of the proposed Framework if purchased alongside the types of equipment, as stated in any subsequent specification. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 40 000 000 GBP in the first year of this Framework Agreement. However, this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
Deadline: approach to market 24 July 2019
Click here for more information.

NHS SUPPLY CHAIN: Patient Monitoring Equipment and Related Accessories and Services
NHS Supply Chain intends to launch a National Framework Agreement for the provision of the following types of Monitoring Systems:
– spot check
– vital signs
– patient (low, Mid and High Acuity)
– pre-hospital transport
– Magnetic Resonance Imaging (MRI) compatible
– central station
– telemetry
– foetal
– cardiac output, Electroencephalograph (EEG)
– Electromyography (EMG)
– Transfer (individual patient modular monitor).
Please note that this framework will not cover the purchase of consumables alone. For the avoidance of doubt consumables will only be in scope of the proposed Framework if purchased alongside the types of equipment, as stated in any subsequent specification. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 40 000 000 GBP in the first year of this Framework Agreement
Deadline: 27 July 2019
Click here for more information.

NHS Supply Chain: Magnetic Resonance (MR) Guided Radiotherapy Treatment Systems
Magnetic Resonance (MR) guided radiotherapy treatment systems including associated options, upgrades, accessories, hardware, software and building works. Note that all applicants must be able to supply a MR radiotherapy treatment system in order to put forward a tender and in order to be successfully-awarded to any future Framework Agreement. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 16 000 000 GBP in the first year of the Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options) is 64 000 000 GBP.
Deadline: approach to market 6 September 2019
Click here for more information.

NHS Supply Chain: Patient Assessment Devices
Blood Pressure Monitoring products, Otoscopes and Ophthalmoscopes, Reusable Stethoscopes, Patient Weighing Scales and Measuring Devices, Proctoscopes (Rectoscopes), Sigmoidoscopes and Anoscopes, Dermatoscopes, Personal Health Monitors, Assessment Lights, General Patient Assessment Products inclusive of Disposable/Single Patient Use Stethoscopes and General Patient Assessment Consumables.
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 3 100 000 GBP to 3 400 000 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Initially a 2 year Framework Agreement with an option to extend for a further period of 2 years. Estimated value, range between 12 400 000 GBP and 13 600 000 GBP.
Deadline: Approach to market date is 20 September 2019
Click here for more information.

NHS Calderdale, Greater Huddersfield & North Kirklees CCG: Posture & Mobility (Wheelchairs) Service
NHS Calderdale, Greater Huddersfield and North Kirklees Clinical Commissioning Groups (CCGS) intend to procure a Wheelchair service to carry out assessments and to supply and maintain wheelchairs.
The service will be required to demonstrate:
• A commitment to providing for the holistic needs of the service user in every aspect of service delivery (i.e. clinical lifestyle, social, educational)
• Design and delivery of services that are personalised, with the service user at the heart of what they do
• An ongoing expectation of quality and service improvement and innovation demonstrated by the provider(s)
• Continued professional development among staff demonstrated by provider(s)
• A commitment to, and evidence from the provider of excellent service user experience, and involvement
• A strong commitment to partnership working with related services and the voluntary sector
• A modern IT system with the ability to accurately record and track activity
• A focus on value for money
The service will be procured as two separate Lots:
Lot 1 – Assessment for wheelchairs
Lot 2 – Supply, maintenance and repair of wheelchairs
Deadline: 1 October 2019
Click here for more information.

NHS Supply Chain: Urology Bowel and Faecal Management
The Framework Agreement will look to include the following range of products – Baby Urine Collection, Bowel and Faecal Management Kits, Catheters, Kits and Maintenance, Catheter accessories, Straps, Valves etc, Catheter Gels, Enuresis Alarms, Mid-Stream Urine Collection, Nephrostomy Urine Drainage, Personal hygiene cleansers, Creams and Foams, Polypropylene Urinals and Funnels, Sheaths, Spigots, Superpubic Catheters, Urine Drainage, Urine Drainage Bags, Urine Meters, Urodynamics. It is anticipated that initial expenditure will be in the region of £18,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term is £78,000,000
Deadline: early engagement (closing date 11 December 2019)
Click here for more information.

NHS Supply Chain: External Breasts Prostheses and Associated Products
The Framework Agreement will look to include the following range of products – Silicone Full Prosthesis, Silicone Partial Prosthesis, Soft Form Temporary Prosthesis and Post-Operative Bras and Accessories. It is anticipated that initial expenditure will be in the region of £5,000,000 to £8,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term is £20,000,000 to £32,000,000.
Deadline: 24 January 2020
Click here for more information.

NHS Supply Chain: Sexual Health and Associated Products
This is a PIN.
The purpose of this notice is to draw attention to a procurement that NHS Supply Chain intends to commence during the subsequent 12 months. The invitation to tender will be the subject of a separate notice and it is that notice to which potential suppliers will need to respond at the appropriate time.
Deadline: 13 March 2020
Click here for more information.

NHS Calderdale CCG: Care Closer to Home
NHS Calderdale CCG is acting in its capacity as commissioner for healthcare services on behalf of the registered population of Calderdale.
This notice is to advise that the commissioner has determined to seek to develop an alliance in respect of the currently contracted providers of services identified within the scope of ‘Care Closer to Home’. Over the next two years, this will entail the providers of services developing and entering into an overarching agreement with the commissioner and other providers to deliver services under existing service contracts in a more collaborative and integrated way to the population served by the CCG.
During the term of the developmental stage outlined above Commissioners will work to develop a strategy for the future commissioning of services and where appropriate, procurement.
Deadline: 31 March 2021
Click here for more information.

SOCIAL MOBILITY COMMISSION

Social Mobility Commission: the relationship between poor health and social mobility
The relationship between poor health and disadvantage is well established. However, there is little evidence of the impact of poor physical health on social mobility. It is often assumed that poor health would be a barrier to social mobility but there is currently no evidence to confirm this.
The Social Mobility Commission is inviting proposals to undertake a study into the relationship between poor health and social mobility. This research forms part of the Social Mobility Commission’s role to produce relevant research that provides new data and insights on social mobility in the UK.
There are a range of ailments that can lead to someone being defined as in ‘poor health’. The research will investigate different types of ailments and their impact on social mobility, whether they are linked to a lack of upward mobility or even linked to downward mobility, and whether there is a causal relationship. The research will investigate the different strategies adopted in different regions to reduce ill-health and whether these have impacted upon social mobility. This work compliments a similar project for which we are inviting proposals regarding social mobility and mental health.
Deadline: 3 May 2019
Click here for more information.